| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |